Shares of GeneNews Ltd (TSE:GEN) rose 6.3% on Friday . The company traded as high as C$0.17 and last traded at C$0.17. Approximately 414,702 shares were traded during trading, a decline of 80% from the average daily volume of 2,057,239 shares. The stock had previously closed at C$0.16.
The firm has a market capitalization of $22.97 million and a price-to-earnings ratio of -4.71.
ILLEGAL ACTIVITY NOTICE: “GeneNews (GEN) Stock Price Up 6.3%” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4244501/genenews-gen-stock-price-up-6-3.html.
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Story: The mechanics of the bid-ask spread in trading
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.